Log in to save to my catalogue

Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical Practice

Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical Practice

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_563c13f21b4841f8a75dd79a480e7205

Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical Practice

About this item

Full title

Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical Practice

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceuticals (Basel, Switzerland), 2023-12, Vol.17 (1), p.63

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Paclitaxel is an anticancer agent efficacious in various tumors. There is large interindividual variability in drug plasma concentrations resulting in a wide variability in observed toxicity in patients. Studies have shown the time the concentration of paclitaxel exceeds 0.05 µM is a predictive parameter of toxicity, making dose individualization p...

Alternative Titles

Full title

Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical Practice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_563c13f21b4841f8a75dd79a480e7205

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_563c13f21b4841f8a75dd79a480e7205

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph17010063

How to access this item